A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Study of the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of HMPL004-6599 in Healthy Male Volunteers
To assess the safety and tolerability of single and multiple doses of HMPL004-6599 in healthy male volunteers